News & Events

Investor Center

Careers

Pipeline

Partnership

About  Us

About Us

Research & Development

Research & Development Pipeline Partership Investor Center News & Events Careers
Home

中文

Contact
   Home    Home-Ch
Press Releases
More Ascletis News
News & Events

Dec 02, 2015 Hangzhou and Shaoxing, China – Goldman Sachs Invested US$20 Million in Ascletis   >>

20151202GS.pdf

Dec 03, 2015   Deputy Governor, Mrs. Liming Liang, meets with Dr. Wu and top executives from Goldman Sachs  >>

20151203DeputyGovernorCh.pdf

Feb 19, 2016   Dr. Jinzi Wu was invited to attend 16 th Annual Conference of Yabuli China Entrepreneurs Forum  >>

20160219Yabuli.pdf    Home-Ch
© 2016 Ascletis. All Rights Reserved
浙公网安备 33010802003344 号
CONTACT US
pr@ascletis.com
hr@ascletis.com
bd@ascletis.com
clinicaltrials@ascletis.com
Contact

Apr 18, 2016   Vice President of Chinese Academy of Sciences visited Ascletis >>

Apr 19, 2016    Ascletis was rewarded as “Outstanding Enterprises” by Shaoxing Municipal Government >>

20160419OutstandingAward.pdf 20160418VPofCAS.pdf
CCTV Report on HCV
Partnership
APASL Panel Review
Partership APASL2015Prof.Wei.pdf

Guidelines for the HCV Treatment

GuidelinesForHCV2015.pdf

Danoprevir

HIV in China
BioDiscover Interview
Corporate Member

公司声明




2015年6月9日/近日,一篇名为 《特大号外:美国公司宣布人类 已经攻克癌症》(以下简称《特 大号外》)的文章在国内各大网 站、论坛、微博及微信朋友圈等 渠道广为传播,引起公众的关注 和热议。作为文中提及的美国阿 尔尼拉姆(Alnylam)公司在国 内的战略合作企业,歌礼生物科 技(杭州)有限公司(以下简称 “歌礼公司”)接到很多患者、 医生和社会公众的咨询电话。鉴 于此,歌礼公司特发此声明以正 视听。                          

                       声明详情 >>

CompanyStatement1.pdf

Ascletis is a specialty therapeutics company dedicated to discovering

and developing important new treatments for cancer and infectious diseases.

HCV IN CHINA